PL EN


Preferences help
enabled [disable] Abstract
Number of results
2006 | 53 | 2 | 383-393
Article title

Elevated level of ambient glucose stimulates the synthesis of high-molecular-weight hyaluronic acid by human mesangial cells. The involvement of transforming growth factor β1 and its activation by thrombospondin-1

Content
Title variants
Languages of publication
EN
Abstracts
EN
The dysregulation of the metabolism of glycosaminoglycan and protein components of extracellular matrix (ECM) is a typical feature of diabetic complications. High glucose-induced enrichment of ECM with hyaluronan (HA) not only affects tissue structural integrity, but influences cell metabolic response due to the variety of effects depending on the HA polymer molecular weight. TSP-1-dependent activation of TGFβ1 axis is known to mediate numerous matrix disorders in diabetes, but its role concerning HA has not been studied so far. In this work we demonstrated that 30 mM D-glucose increased the incorporation of [3H]glucosamine in high-molecular-weight (> 2000 kDa) HA of medium and matrix compartments of human mesangial cultures. Simultaneously, the synthesis of HA with lower molecular weight and HA degradation were not altered. The cause of the increased high-molecular-weight HA synthesis consisted in the up-regulation of hyaluronan synthase (HAS) 2 mRNA without alterations of the expression of HAS3, which generates HA of lower molecular weight. D-Glucose at 30 mM also stimulated the production of transforming growth factor β1 (TGFβ1), the excessive activation of which was determined by the up-regulation of thrombospondin-1 (TSP-1). The blockage of TGFβ1 action either by neutralizing anti-TGFβ1 antibodies or by quenching the TGFβ1 activation (with TSP-1-derived synthetic GGWSHW peptide) abolished the effect of high glucose on HAS2 mRNA expression and normalized the synthesis of HA. Exogenous human TGFβ1 had the same effect on HAS2 expression and HA synthesis as high glucose treatment. Therefore, we supposed that TSP-1-dependent TGFβ1 activation is involved in the observed high glucose effect on HA metabolism. Since high-molecular-weight HA polymers, unlike middle- and low-molecular weight HA oligosaccharides, are known to possess anti-inflammatory and anti-fibrotic functions, we suppose that the enrichment of mesangial matrix with high-molecular-weight HA may represent an endogenous mechanism to limit renal injury in diabetes.
Year
Volume
53
Issue
2
Pages
383-393
Physical description
Dates
published
2006
received
2005-11-20
revised
2006-02-21
accepted
2006-03-03
(unknown)
2006-05-29
References
  • Asselman M, Verhulst A, Van Ballegoijen ES, Bangma CH, Verkoelen CF, De Broe ME (2005) Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells. Kidney Int 68: 71-83.
  • Breborowicz A, Korybalska K, Grzybowski A, Wieczorowska-Tobis K, Martis L, Oreopoulos DG (1996) Synthesis of hyaluronic acid by human peritoneal mesothelial cells: effect of cytokines and dialysate. Perit Dial Int 16: 374-8.
  • Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribiero SMF, Lawler J, Hynes RO, Boivin GP, Bouk N (1998) Thrombospondin-1 is a major activator of TGFβ1 in vivo. Cell 93: 1159-1170.
  • Dunlop ME, Clark S, Mahadevan P, Muggli E, Larkins RE (1996) Production hyaluronan by glomerular mesangial cells in response to fibronectin and platelet-derived growth factor. Kidney Int 50: 40-44.
  • Ellis IR, Schor SL (1998) Differential motogenic and biosynthetic response of fetal and adult skin fibroblasts to TGF-beta isoforms. Cytokine 10: 281-289.
  • Ginetzinsky AG (1958) Role of hyaluronidase in the re-absorption of water in renal tubules. Nature 182: 1218-1222.
  • Göransson V, Johnsson C, Jakobson A, Heldin P, Hällgren R, Hansell P (2004) Renal hyaluronan accumulation and hyaluronan expression after ischaemia-reperfusion injury in the rat. Nephrol Dial Transplant 19: 823-830.
  • Hascall VC, Majors AK, De La Motte CA, Evanko SP, Wang A, Drazba JA, Strong SA, Wight TN (2004) Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta 1673: 3-12.
  • Haubeck HD, Kock R, Fisher DC, Van der Leur E, Hoffmeister K, Greiling H (1995) Transforming growth factor beta1, a major stimulator of hyaluronan synthesis in human synovial lining cells. Arthritis Rheum 38: 669-677.
  • Heldin P, Laurent TC, Heldin C-H (1989) Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 258: 919-922.
  • Hugo C (2003) The thrombospondin 1 - TGF-β axis in fibrotic renal disease. Nephrol Dial Transplant 18: 1241-1245.
  • Jacobson A, Brinck J, Briskin MJ, Spicer A, Heldin P (2000) Expression of human hyaluronan synthases in response to external stimuli. Biochem J 348: 29-35.
  • Jones S, Jones S, Phillips AO (2001) Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy. Kidney Int 59: 1739-1749.
  • Kuznetsova SA, Day AJ, Mahoney DJ, Rugg MS, Mosher DF, Roberts DD (2005) The N-terminal module of thrombospondin-1 interacts with the link domain of TSG-6 and enhances its covalent association with the heavy chains of inter-alpha-trypsin inhibitor. J Biol Chem 280: 30899-30908.
  • Laurent TC, Fraser JRE (1992) Hyaluronan. FASEB J 6: 2397-2404.
  • Locci P, Marinucci L, Lilli C, Martinese D, Becchetti E (1995) Transforming growth factor β1 - hyaluronic acid interaction. Cell Tissue Res 281: 317-324.
  • Mahadevan P, Larkins RG, Fraser JR, Fosang AJ, Dunlop ME (1995) Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandim production and reduced sulphated proteoglycan. Diabetologia 38: 298-305.
  • McLennan SV, Death AK, Fisher EJ, Williams PF, Yue DK, Turtle JR (1999) The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy. Cell Mol Biol 45: 123-135.
  • Noble PW (2002) Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biology 21: 25-29.
  • Oguchi T, Ishiguro N (2004) Differential stimulation of three forms of hyaluronan synthase by TGF-beta, IL-1beta and TNF-alpha. Connect Tissue Res 45: 197-205.
  • Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, Wada J, Shikata Y, Makino H (2003) Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52: 2586-2593.
  • Poczatek MH, Hugo Ch, Darley-Usmar V, Murphy-Ulrich JE (2000) Glucose stimulation of transforming growth factor-β bioactivity in mesangial cells is mediated by thrombospondin 1. Am J Pathol 157: 1353-1363.
  • Recklies AD, White C, Melching L, Roughley P (2001) Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J 354: 17-24.
  • Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, Murphy-Ulrich JE (1995) Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J Biol Chem 270: 7304-7310.
  • Selbi W, De La Motte C, Hascall V, Phillips A (2004) BMP-7 modulates hyaluronan-mediated proximal tubular cell-monocyte interaction. J Am Soc Nephrol 15: 1199-1211.
  • Stuhlmeier KM, Pollaschek C (2004) Differential effect of transforming growth factor β (TGF-β) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-β-induced hyaluronan synthase 1 activation. J Biol Chem 279: 8753-8760.
  • Sugiyama Y, Shimada A, Sayo T, Sakai S, Inoue S (1998) Putative hyaluronan synthase mRNAs are expressed in mouse skin and TGF-beta upregulates their expression in cultured human skin cells. J Invest Dermatol 110: 116-121.
  • Suzuki K, Yamamoto T, Usui T, Suzuki K, Heldin P, Yamashita H (2003) Expression of hyaluronan synthase in intraocular proliferative diseases: regulation of expression in human vascular endothelial cells by transforming growth factors-β. Jpn J Ophthalmol 47: 557-564.
  • Takeda M, Babazono T, Nitta K, Iwamoto Y (2001) High glucose stimulates hyaluronan production by renal intestinal fibrolasts through the protein kinase C and transforming growth factor-β cascade. Metabolism 50: 789-794.
  • Tammi MI, Day AJ, Turley EA (2001) Hyaluronan and homeostasis: a balancing act. J Biol Chem 277: 4581-4584.
  • Tanimoto K, Suzuki A, Ohno S, Honda K, Tanaka N, Doi T, Yoneno K, Ohno-Nakahara M, Nakatani Y, Ueki M, Tanne K (2004) Effects of TGF-β on hyaluronan anabolism derived from the synovial membrane of the rabbit temporomandibular joint. J Dent Res 83: 40-44.
  • Usui T, Amano S, Tetsuro O, Suzuki K, Miyata K, Araie M, Heldin P, Yamashita H (2000) Expression regulation of hyaluronan synthase in corneal endothelial cells. Invest Ophthalmol Vis Sci 41: 3261-3267.
  • Usui T, Nakajiama F, Ideta R, Kaji Y, Suzuki Y, Araie M, Miyauchi S, Heldin P, Yamashita H (2003) Hyaluronan synthase in trabecular meshwork cells. Br J Ophthalmol 87: 357-360.
  • van Kooten C, Daha MR, van Es LA (1999) Tubular epithelial cells: a critical cell type in the regulation of renal inflammatory process. Exp Nephrol 7: 429-437.
  • Wang A, Hascall VC (2004) Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion. J Biol Chem 279: 10279-10285.
  • Wells A, Larsson E, Hanas E, Laurent T, Hallgren R, Tufveson G (1993) Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 55: 1346-1349.
  • Yasui T, Akatsuka M, Tobetto K, Umemoto J, Ando T, Jamashita K, Hayakawa T (1992) Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase-1 (TIMP-1) in bovine articular chondrocytes. Biomed Res 13: 343-348.
  • Yevdokimova NYu, Freshney RI (1997) Activation of paracrine growth factor by a heparin sulphate induced by glucocorticoid in A549 lung carcinoma cells. Br J Cancer 76: 281-289.
  • Yevdokimova NYu, Abdel Wahab N, Mason RM (2001) Thrombospondin-1 is the key activator of TGF-β1 in human mesangial cells exposed to high glucose. J Am Soc Nephrol 12: 703-712.
  • Yevdokimova NYu (2003) High glucose-induced alterations of extracellular matrix of human skin fibroblasts are not dependent on TSP-1-TGFβ1 pathway. J Diabetes Complications 17: 355-365.
  • Ziyadeh FN (2004) Mediators of diabetic kidney disease: the case for TGF-β as the major mediator. J Am Soc Nephrol 15 (Suppl 1): S55-S57.
Document Type
Publication order reference
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv53p383kz
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.